Misleading clinical evidence and systematic reviews on ivermectin for COVID-19

dc.contributor.authorGaregnani, Luis Ignacio
dc.contributor.authorMadrid, Eva
dc.contributor.authorMeza, Nicolás
dc.date.accessioned2022-11-30T02:46:30Z
dc.date.available2022-11-30T02:46:30Z
dc.date.issued2021
dc.facultadFacultad de Medicinaen_ES
dc.file.nameMadrid_Misl2021.pdf
dc.identifier.citationGaregnani LI, Madrid E, Meza N. BMJ Evidence-Based Medicine Epub ahead of print: [please include Day Month Year]. doi:10.1136/bmjebm-2021-111678en_ES
dc.identifier.doi10.1136/bmjebm-2021-111678
dc.identifier.urihttp://repositoriobibliotecas.uv.cl/handle/uvscl/7401
dc.languageen
dc.publisherBmj
dc.rightsThis article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non- commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
dc.sourceBMJ Evidence-Based Medicine
dc.titleMisleading clinical evidence and systematic reviews on ivermectin for COVID-19
dc.typeArticulo
uv.departamentoCentro Interdisciplinario de Estudios en Salud (CIESAL)

Archivos

Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Madrid_Misl2021.pdf
Tamaño:
213.58 KB
Formato:
Adobe Portable Document Format